Background {#Sec1}
==========

Out-of-hospital cardiac arrest (OHCA) is a major public health problem worldwide. Approximately 330,000 individuals in the United States and 275,000 individuals in Europe experience OHCAs each year \[[@CR1], [@CR2]\]. The survival rate has steadily improved in OHCA cases from cardiac etiologies, whereas the survival rate for OHCA from all etiologies is about 10 %, similar to the rate three decades ago \[[@CR1], [@CR3], [@CR4]\]. Most patients who survive an OHCA are resuscitated in the prehospital setting and are subsequently transported to emergency hospitals. Transporting all OHCA patients to emergency hospitals results in unnecessary consumption of valuable resources and exposes paramedics and the public to the risks of high-speed transportation \[[@CR5]\].

Several studies have been conducted to prospectively determine and test the unequivocal termination of resuscitation (TOR) rules. The 2015 American Heart Association (AHA) Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care recommends that emergency medical service (EMS) personnel in prehospital settings should follow TOR rules in the protocols for basic life support (BLS) and advanced life support (ALS) \[[@CR6]\]. The BLS TOR rule has three criteria, and all three of the following criteria must be present before terminating BLS resuscitative attempts for adult patients with OHCA: arrest was not witnessed by EMS personnel; no return of spontaneous circulation (ROSC) in the field; and no shock was delivered \[[@CR7]\]. The ALS TOR rule recommends considering terminating resuscitation efforts when all of the following four criteria are met in the field: arrest was not witnessed; bystander cardiopulmonary resuscitation (CPR) was not provided; no ROSC after ALS care in the field; and no shock was delivered \[[@CR8]\].

In a prospective study, the BLS TOR rule was 100 % predictive of death \[[@CR9]\]. In several validation studies, both TOR rules were reported to have a high specificity and positive predictive value (PPV) for death or poor neurological outcomes \[[@CR7], [@CR10], [@CR11]\]. The implementation of the TOR rules significantly reduces the rate of transport of futile OHCA. However, the European Resuscitation Council (ERC) guideline challenged the TOR rules and argued that applying the TOR rules led to an unexpected survival of 3.4--9 % of OHCA patients without sustained ROSC in the prehospital setting \[[@CR12], [@CR13]\]. Moreover, these validation studies were performed in patients with OHCA of presumed cardiac etiology and excluded patients with OHCA from noncardiac etiologies, such as suffocation, pulmonary embolism, incidental hypothermia, and vascular disease \[[@CR7], [@CR9]--[@CR11]\]. Although the TOR rules have been validated in patients with OHCA from all etiologies in small population studies, there have been no studies specifically focused on OHCA of noncardiac etiology \[[@CR14], [@CR15]\]. As a result, it remains unclear whether the TOR rules are useful in patients with OHCA both of cardiac and noncardiac etiologies.

In this study, we assessed the validity of the BLS and ALS TOR rules for patients suffering from OHCA of cardiac or noncardiac etiology using data from the Survey of Survivors after Cardiac Arrest, which was collected in the Kanto Area of Japan in 2012 (SOS-KANTO 2012).

Methods {#Sec2}
=======

Setting and design {#Sec3}
------------------

SOS-KANTO 2012 is a prospective, multicenter (including 67 emergency hospitals) observational study conducted between January 2012 and March 2013 in the Kanto region of Japan. The design and data collection methods used in SOS-KANTO 2012 have been reported in detail in prior studies \[[@CR16], [@CR17]\]. The Kanto region is made up of primarily urban areas, including Tokyo. The institutional ethics committees of each participating institution approved the study with a waiver for informed consent in order to protect participant anonymity.

The EMS system in Japan {#Sec4}
-----------------------

The EMS system in Japan has been explained in several previous studies \[[@CR11], [@CR18]\]. The EMS system is supervised by the Fire and Disaster Management Agency of Japan and is operated by each municipal government. All EMS personnel are certified to perform CPR according to the Japanese resuscitation guidelines produced by the Japan Resuscitation Council. Generally, the ambulance crew consists of three EMS personnel, including at least one emergency lifesaving technician (ELST). ELSTs may perform several resuscitation methods under the supervision of online medical control, including the operation of a semiautomated external defibrillator, insertion of a supraglottic airway device, and insertion of a peripheral intravenous line. Specially trained ELSTs have been able to perform endotracheal intubation since 2004 and to administer adrenaline intravenously under the supervision of online medical control since 2006. EMS personnel in Japan are not legally permitted to terminate resuscitation in the field, and all OHCA patients are transported to hospitals, except in cases where death is certain \[[@CR18], [@CR19]\].

Participants {#Sec5}
------------

All OHCA patients transported by EMS personnel to participating institutions during the study were eligible for inclusion in SOS-KANTO 2012. Of these patients, the present study included only adults (18 years or older) suffering from nontraumatic OHCA. In addition, the following cases were excluded: cases with missing data regarding inclusion criteria or main outcomes (e.g., age, etiology of cardiac arrest, outcomes 1 month after cardiac arrest); cases with initial resuscitation performed inside the hospital and/or missing data for onset location; cases in which it was unknown whether BLS or ALS was performed by EMS personnel; and cases with missing data regarding BLS/ALS TOR criteria. Eligible participants were divided into two groups: those with OHCA from cardiac etiologies, and those with OHCA from noncardiac etiologies. Cases involving BLS and ALS were evaluated according to the BLS and ALS TOR rules, respectively.

Data collection and definition {#Sec6}
------------------------------

The EMS personnel collected prehospital data based on the Utstein-style template \[[@CR20]\]. The absence of prehospital ROSC, one component of the TOR rule, was defined as no ROSC despite resuscitation effort of the EMS personnel until hospital arrival. Physicians collected data regarding in-hospital treatments and outcomes, and determined the etiology of OHCA, including cardiac (presumed cardiac origin) and noncardiac (e.g., asphyxia, trauma, aortic disease, drawing, cerebrovascular disease, and drug overdose). If more than one etiology was possible (e.g., ventricular fibrillation arrest leading to a fall from height), the most likely primary cause was recorded at the discretion of physicians.

Outcome measurements {#Sec7}
--------------------

The primary outcome was survival with favorable neurological outcomes 1 month after cardiac arrest, defined as a Glasgow--Pittsburgh cerebral-performance category of 1 (good performance) or 2 (moderate disability) on a five-category scale \[[@CR21], [@CR22]\]. The other categories of 3 (severe disability), 4 (vegetative state), and 5 (death) were defined as unfavorable neurological outcomes. The secondary outcome was mortality 1 month after cardiac arrest.

Statistical analysis {#Sec8}
--------------------

Descriptive statistics were calculated for all variables of interest. Continuous variables were reported as means and standard deviations, whereas categorical variables were summarized using counts and percentages. The BLS and ALS TOR rules were evaluated as diagnostic tests. The test characteristics, including sensitivity, specificity, false-positive rate (FPR), PPV and negative predictive value, were reported using 95 % confidence intervals (CIs). Lower sensitivity meant that more patients, who eventually died, were predicted to have good outcomes. AHA and ERC guidelines recommend the FPR to be close to 0 % and classify the reporting imprecision of a diagnostic test for prognostication as serious when the upper limit of the 95 % CI is \>10 % \[[@CR23], [@CR24]\]. Statistical analysis was performed using IBM SPSS for Mac Version 22.0 (IBM Corp., Armonk, NY, USA).

Results {#Sec9}
=======

The study flow chart is shown in Fig. [1](#Fig1){ref-type="fig"}. During the survey period, a total of 16,452 patients with OHCA were documented. Of these, the following cases were excluded: 288 patients aged \<18 years, 1075 patients with traumatic OHCA, 494 patients with missing etiology of arrest data, 239 cases with missing outcome data, 260 patients who initially received CPR in the hospital, and 230 cases with missing data for onset location. Therefore, 13,866 cases of nontraumatic adult OHCA were eligible for inclusion. However, an additional 724 cases were excluded because it was unknown whether BLS or ALS had been performed, and 1637 cases were excluded due to missing data regarding the TOR criteria (12 cases, unknown witnessed events; 106 cases, unknown shock delivery; and 1519 cases, unknown prehospital ROSC). As a result, 11,505 patients were enrolled in the present study. These patients were divided into two groups, with 6138 cases of OHCA from presumed cardiac etiologies and 5367 cases of OHCA from noncardiac etiologies. In total, 5424 patients received BLS (2818 cardiac cases and 2606 noncardiac cases) and 6081 patients received ALS (3320 cardiac cases and 2761 noncardiac cases).Fig. 1Flow diagram of the study population. The population for this study was obtained from data in the Survey of Survivors after Cardiac Arrest, which were collected in the Kanto Area of Japan from January 2012 to March 2013. *ALS* advanced life support, *BLS* basic life support, *EMS* emergency medical service, *OHCA* out-of-hospital cardiac arrest, *ROSC* return of spontaneous circulation, *TOR* termination of resuscitation

The patient characteristics are presented in Table [1](#Tab1){ref-type="table"}. The mean patient age was 72.4 years, and 6884 patients were men (59.8 %). Cardiac arrest occurred at home in 8395 cases (73.0 %). The mean time from call to ambulance arrival on the scene was 8.0 minutes, and the mean time from call to hospital arrival was 35.3 minutes. In 845 cases (7.3 %), the initial observed rhythm upon arrival was ventricular fibrillation or ventricular tachycardia. Advanced airways were placed in 5368 patients (46.7 %), and adrenaline was administered to 2287 patients (19.9 %). In total, BLS was performed on 5424 patients (47.1 %) and ALS was performed on 6081 patients (52.9 %).Table 1Clinical and prehospital characteristics of out-of-hospital cardiac arrest patients by groupCharacteristicTotal (*n* = 11,505)Cardiac etiology (*n* = 6138)Noncardiac etiology (*n* = 5367)Age (years)72.4 ± 15.873.4 ± 14.571.2 ± 17.1Male6884 (59.8)3827 (62.3)3057 (57.0)Location of arrest Home8395 (73.0)4365 (71.1)4030 (75.1) Public space (indoor)352 (3.1)217 (3.5)135 (2.5) Public space (outdoor)622 (5.4)435 (7.1)187 (3.5) Other2136 (18.6)1121 (18.3)1015 (18.9)EMS care interval (minutes) Call to arrival of ambulance at scene8.0 ± 3.68.0 ± 3.77.9 ± 3.6 Call to hospital arrival35.3 ± 3.635.4 ± 11.035.3 ± 12.0Initial rhythm Ventricular fibrillation/ventricular tachycardia845 (7.3)752 (12.3)93 (1.7) Pulseless electrical activity2369 (20.6)1111 (18.1)1258 (23.4) Asystole7550 (65.6)3909 (63.7)3641 (67.8) Others or unknown741 (6.4)366 (6.0)375 (7.0)Advanced airway procedure5368 (46.7)2941 (47.9)2427 (45.2)Prehospital adrenaline administration2287 (19.9)1220 (19.9)1067 (19.9)BLS performed by EMS5424 (47.1)2818 (46.9)2606 (48.6) Met BLS TOR criteria419320602133ALS performed by EMS6081 (52.9)3320 (54.1)2761 (51.4) Met ALS TOR criteria1701956745Arrest witnessed by Bystander5473 (47.6)2881 (46.9)2592 (48.3) EMS/first responder929 (8.1)480 (7.8)449 (8.4)Prehospital defibrillation (layperson and EMS)1565 (13.6)1249 (20.3)316 (5.9)Bystander-initiated CPR4231 (36.8)2226 (36.3)2005 (37.4)Prehospital ROSC1070 (9.3)570 (9.3)500 (9.3)Data presented as means ± standard deviations for continuous variables and numbers (percentage) for categorical values*ALS* advanced life support, *BLS* basic life support, *CPR* cardiopulmonary resuscitation, *EMS* emergency medical service, *ROSC* return of spontaneous circulation, *TOR* termination of resuscitation

Regarding the TOR rules criteria, cardiac arrests were witnessed by bystanders and EMS personnel in 5473 (47.6 %) cases and 929 (8.1 %) cases, respectively. Prehospital defibrillation was delivered in 1565 cases (13.6 %), bystander-initiated CPR was performed in 4231 cases (36.8 %), and ROSC was achieved in the prehospital setting in 1070 cases (9.3 %). In summary, 4193 and 1701 patients met all BLS and ALS TOR criteria, respectively.

Characteristics regarding in-hospital treatment and outcome data are presented in Table [2](#Tab2){ref-type="table"}. Shocks were delivered in the emergency room in 1144 cases (9.9 %), and adrenaline was administered in 9086 cases (79.0 %). Of the 2321 patients (20.2 %) who survived until hospital admission, coronary angiography and therapeutic hypothermia was performed in 520 cases (22.4 %) and 606 cases (26.1 %), respectively. One month after admission, 11,161 cases (97.0 %) had unfavorable neurological outcomes, and 10,933 patients (95.0 %) had died.Table 2In-hospital management and 1-month outcomes for out-of-hospital cardiac arrest patients by groupCharacteristicTotal (*n* = 11,505)Cardiac etiology (*n* = 6138)Noncardiac etiology (*n* = 5367)Defibrillation in ER1144 (9.9)831 (13.5)313 (5.8)Adrenaline administration in ER9086 (79.0)4819 (78.5)4267 (79.5)Survival until hospital admission2321 (20.2)1112 (18.1)1209 (22.5)Coronary angiography^a^520 (22.4)483 (43.4)37 (3.1)Therapeutic hypothermia^a^606 (26.1)437 (39.3)169 (14.0)Clinical outcomes 1 month after admissionNeurologically favorable outcome (CPC 1 or 2)344 (3.0)279 (4.5)65 (1.2)Neurologically unfavorable outcome (CPC 3--5)11,161 (97.0)5859 (95.5)5302 (98.8)Survival572 (5.0)410 (6.7)162 (3.0)Death10,933 (95.0)5728 (93.3)5205 (97.0)Data presented as numbers (percentage) for categorical values^a^Proportion calculated using the numbers of patients who survived until hospital admission as the denominator*CPC* cerebral performance category, *ER* emergency room

Diagnostic accuracy of the TOR rules for all patients {#Sec10}
-----------------------------------------------------

The characteristics of the diagnostic tests for the TOR rules for 1-month neurological outcomes and mortality are presented in Tables [3](#Tab3){ref-type="table"} and [4](#Tab4){ref-type="table"}, respectively. For all cases (OHCA from both cardiac and noncardiac etiologies), the BLS TOR rule had a specificity of 0.971 (95 % CI: 0.942--0.988), a FPR of 2.9 % (95 % CI: 1.2--5.8 %), and a PPV of 0.998 (95 % CI: 0.997--0.999) for predicting neurologically unfavorable outcomes at 1 month (Table [3](#Tab3){ref-type="table"}). In this same group, the BLS TOR rules had a specificity of 0.918 (95 % CI: 0.884--0.945), a FPR of 8.2 % (95 % CI: 5.5--11.6 %), and a PPV of 0.993 (95 % CI: 0.990--0.996) for 1-month mortality (Table [4](#Tab4){ref-type="table"}). The ALS TOR rule in patients with OHCA from both cardiac and noncardiac etiologies had a specificity of 0.939 (95 % CI: 0.873--0.977), a FPR of 6.1 % (95 % CI: 2.3--12.7 %), and a PPV of 0.996 (95 % CI: 0.992--0.999) for predicting neurologically unfavorable outcomes at 1 month (Table [3](#Tab3){ref-type="table"}). The ALS TOR rule had a specificity of 0.913 (95 % CI: 0.869--0.946), a FPR of 8.7 % (95 % CI: 5.4--13.1 %), and a PPV of 0.988 (95 % CI: 0.982--0.993) for 1-month mortality (Table [4](#Tab4){ref-type="table"}).Table 3Diagnostic accuracy of termination of resuscitation rules for 1-month neurological outcomesEtiology of cardiac arrestNeurologically unfavorable outcomeNeurologically favorable outcomeSensitivity (95 % CI)Specificity (95 % CI)FPR (95 % CI)PPV (95 % CI)NPV (95 % CI)BLS TOR ruleAll typesMet criteria418670.8080.9712.9 %0.9980.193Did not meet criteria993238(0.797--0.819)(0.942--0.988)(1.2--5.8 %)(0.997--0.999)(0.172--0.217)Cardiac etiologyMet criteria205730.7850.9851.5 %0.9990.257Did not meet criteria563195(0.769--0.801)(0.956--0.997)(0.3--4.4 %)(0.996--1.000)(0.226--0.290)Noncardiac etiologyMet criteria212940.8320.9158.5 %0.9980.091Did not meet criteria43043(0.817--0.846)(0.796--0.976)(2.4--20.4 %)(0.995--0.999)(0.067--0.121)ALS TOR ruleAll typesMet criteria169560.3530.9396.1 %0.9960.021Did not meet criteria428793(0.341--0.365)(0.873--0.977)(2.3--12.7 %)(0.992--0.999)(0.017--0.026)Cardiac etiologyMet criteria95330.2940.9633.7 %0.9970.033Did not meet criteria228678(0.279--0.310)(0.896--0.992)(0.8--10.4 %)(0.991--0.999)(0.026--0.041)Noncardiac etiologyMet criteria74230.2710.83316.7 %0.9960.007Did not meet criteria200115(0.254--0.288)(0.586--0.964)(3.6--41.4 %)(0.988--0.999)(0.004--0.012)*ALS* advanced life support, *BLS* basic life support, *CI* confidence interval, *FPR* false-positive rate, *NPV* negative predictive value, *PPV* positive predictive value, *TOR* termination of resuscitationTable 4Diagnostic accuracy of termination of resuscitation rules for 1-month mortalityEtiology of cardiac arrestDeathsSurvivalSensitivity (95 % CI)Specificity (95 % CI)FPR (95 % CI)PPV (95 % CI)NPV (95 % CI)BLS TOR ruleAll typesMet criteria4165280.8200.9188.2 %0.9930.255Did not meet criteria917314(0.809--0.830)(0.884--0.945)(5.5--11.6 %)(0.990--0.996)(0.231--0.280)Cardiac etiologyMet criteria2044160.7980.9386.2 %0.9920.318Did not meet criteria517241(0.782--0.814)(0.901--0.964)(3.6--9.9 %)(0.987--0.996)(0.285--0.352)Noncardiac etiologyMet criteria2121120.8410.85914.1 %0.9940.154Did not meet criteria40073(0.826--0.855)(0.766--0.925)(7.5--23.4 %)(0.990--0.997)(0.123--0.190)ALS TOR ruleAll typesMet criteria1681200.2870.9138.7 %0.9880.048Did not meet criteria4170210(0.276--0.299)(0.869--0.946)(5.4--13.1 %)(0.982--0.993)(0.042--0.055)Cardiac etiologyMet criteria94790.2990.9415.9 %0.9910.061Did not meet criteria2220144(0.283--0.315)(0.891--0.973)(2.7--10.9 %)(0.982--0.996)(0.052--0.071)Noncardiac etiologyMet criteria734110.2730.85714.3 %0.9850.033Did not meet criteria195066(0.257--0.291)(0.759--0.926)(7.4--24.1 %)(0.974--0.993)(0.025--0.042)*ALS* advanced life support, *BLS* basic life support, *CI* confidence interval, *FPR* false-positive rate, *NPV* negative predictive value, *PPV* positive predictive value, *TOR* termination of resuscitation

Diagnostic accuracy of the TOR rules for patients with OHCA of cardiac etiology {#Sec11}
-------------------------------------------------------------------------------

In patients with OHCA from cardiac etiologies, the BLS TOR rule had a specificity of 0.985 (95 % CI: 0.956--0.997), a FPR of 1.5 % (95 % CI: 0.3--4.4 %), and a PPV of 0.999 (95 % CI: 0.996--1.000) for predicting neurologically unfavorable outcomes at 1 month (Table [3](#Tab3){ref-type="table"}). In this same group, the BLS TOR rules had a specificity of 0.938 (95 % CI: 0.901--0.964), a FPR of 6.2 % (95 % CI: 3.6--9.9 %), and a PPV of 0.992 (95 % CI: 0.987--0.996) for 1-month mortality (Table [4](#Tab4){ref-type="table"}). The ALS TOR rule for patients with OHCA from cardiac etiologies had a specificity of 0.963 (95 % CI: 0.896--0.992), a FPR of 3.7 % (95 % CI: 0.8--10.4 %), and a PPV of 0.997 (95 % CI: 0.991--0.999) for predicting neurologically unfavorable outcomes at 1 month (Table [3](#Tab3){ref-type="table"}). For 1-month mortality, the ALS TOR rule had a specificity of 0.941 (95 % CI: 0.891--0.973), a FPR of 5.9 % (95 % CI: 2.7--10.9 %), and a PPV of 0.991 (95 % CI: 0.982--0.996) (Table [4](#Tab4){ref-type="table"}).

Diagnostic accuracy of the TOR rules for patients with OHCA of noncardiac etiology {#Sec12}
----------------------------------------------------------------------------------

In patients with OHCA from noncardiac etiologies, the BLS TOR rule had a specificity of 0.915 (95 % CI: 0.796--0.976), a FPR of 8.5 % (95 % CI: 2.4--20.4 %), and a PPV of 0.998 (95 % CI: 0.995--0.999) for predicting neurologically unfavorable outcomes at 1 month (Table [3](#Tab3){ref-type="table"}). In this same group, the BLS TOR rules had a specificity of 0.859 (95 % CI: 0.766--0.925), a FPR of 14.1 % (95 % CI: 7.5--23.4 %), and a PPV of 0.994 (95 % CI: 0.990--0.997) for mortality at 1 month (Table [4](#Tab4){ref-type="table"}). The ALS TOR rule for patients with OHCA from noncardiac etiologies had a specificity of 0.833 (95 % CI: 0.586--0.964), a FPR of 16.7 % (95 % CI: 3.6--41.4 %), and a PPV of 0.996 (95 % CI: 0.988--0.999) for predicting neurologically unfavorable outcomes at 1 month (Table [3](#Tab3){ref-type="table"}). For 1-month mortality, the ALS TOR rule had a specificity of 0.857 (95 % CI: 0.759--0.926), a FPR of 14.3 % (95 % CI: 7.4--24.1 %), and a PPV of 0.985 (95 % CI: 0.974--0.993) (Table [4](#Tab4){ref-type="table"}).

Characteristics of unexpected survivors with neurologically favorable outcome {#Sec13}
-----------------------------------------------------------------------------

Seven and six unexpected survivors had good neurological outcomes in the BLS and ALS TOR rules, respectively (see Additional file [1](#MOESM1){ref-type="media"}: Table S1). Of these 13 cases, incidental hypothermia, pulmonary embolism, drug overdose, and suffocation accounted for seven cases with noncardiac etiologies. Extracorporeal cardiopulmonary resuscitation (ECPR) was performed in five cases.

Discussion {#Sec14}
==========

We investigated the diagnostic accuracy of the BLS and ALS TOR rules for predicting unfavorable neurological outcomes and mortality 1 month after OHCA using data from SOS-KANTO 2012. Both TOR rules showed a high specificity and PPV and a low FPR in patients with OHCA of cardiac etiology. However, the TOR rules had a high PPV but low specificity and high FPR in patients with OHCA of noncardiac etiology. The imprecision of the BLS and ALS TOR rules is summarized in Table [5](#Tab5){ref-type="table"}.Table 5Imprecision of basic and advanced life support termination of resuscitation rulesEtiologyImprecisionFor predicting 1-month unfavorable neurological outcome BLS TOR ruleCardiacAcceptableNoncardiacSerious ALS TOR ruleCardiacSeriousNoncardiacSeriousFor predicting 1-month mortality BLS TOR ruleCardiacAcceptableNoncardiacSerious ALS TOR ruleCardiacSeriousNoncardiacSeriousImprecision is classified as acceptable and serious when the upper limit of the 95 % confidence interval of the false-positive rate is ≤10 % and \>10 %, respectively*ALS* advanced life support, *BLS* basic life support, *TOR* termination of resuscitation

For patients in the cardiac etiology group, the diagnostic accuracy of the TOR rules was similar to results reported in prior studies conducted in North America and Japan \[[@CR7], [@CR9]--[@CR11]\]. Similarly, the effectiveness of both TOR rules for predicting neurologically unfavorable outcomes and death after OHCA in Japan was demonstrated in this present study. In cases of OHCA due to cardiac etiology, both TOR rules were useful in determining when to terminate resuscitation efforts in the prehospital setting.

This study had several strengths, particularly regarding the population and sample size. Firstly, the efficacy of the TOR rules was validated in all patients transported to emergency hospitals in a densely populated area of Japan. Secondly, we included almost all OHCA patients in this area of Japan because EMS personnel in Japan are legally obligated to transport OHCA patients to the hospital, except in cases of obvious mortality \[[@CR19], [@CR25]\]. In previous studies of this topic, TOR occurred in approximately 17 % of patients in the prehospital setting \[[@CR10]\].

For patients in the noncardiac etiology group, the specificity of both TOR rules for neurologically unfavorable outcomes and mortality at 1 month were relatively low. Conversely, the PPVs of both TOR rules for patients in the noncardiac etiology group were very high and similar to the PPVs for patients in the cardiac etiology group. The pretest probability for 1-month mortality and unfavorable outcomes was 97.0 % and 98.8 %, respectively; therefore a high PPV depends on a high pretest probability.

The etiologies of cardiac arrest were categorized clinically according to the Utstein-style guidelines for cardiac arrest data reporting \[[@CR20]\]. Although the survival rate for patients with OHCA of noncardiac etiology is very poor, survival rates differ extensively for patients with OHCA of noncardiac etiology \[[@CR26]\]. For instance, in patients with OHCA resulting from respiratory disease, asphyxia, drug overdose, and incidental hypothermia, the survival rate is higher than in those from other noncardiac etiologies \[[@CR26]\]. In the present study, special circumstances, such as incidental hypothermia or drug overdose, were relatively common etiologies of noncardiac unexpected survivors. The ERC guideline also recommends that EMS personnel should consider continuing CPR during transport to hospital in patients with OHCAs with presumed reversible causes, such as drug overdose and hypothermia \[[@CR12]\]. Moreover, it is often difficult to determine the etiology of cardiac arrest in the prehospital setting \[[@CR27]\]. Cost-effectiveness is very important in the TOR rule. Previous researchers have reported that applying the TOR rules reduces approximately 40--50 % of futile transportation and further resuscitation efforts \[[@CR7], [@CR9]\]. However, the decision of the TOR is more challenging in contrast to other interventions. It has been argued that success rates of \<1 % still justify the resuscitation effort \[[@CR12]\]. According to our results, the TOR rules are less useful for OHCAs of noncardiac etiology than those of cardiac etiology. Until these discrepancies are resolved, it would be necessary to develop new TOR rules that are effective for OHCAs from both cardiac and noncardiac etiologies. At the least, we consider that the TOR rules should not be applied in cases of presumed reversible etiologies.

According to our results, the upper limit of the FPR of the ALS TOR rule was near 10 %, which is high for cardiac etiology. As advanced therapies (i.e., ECPR) become widely available, TOR rules require integration with guidance on suitability for these therapies \[[@CR10], [@CR28], [@CR29]\]. For example, the low end-tidal carbon dioxide (EtCO~2~) value during CPR may indicate a poor prognosis \[[@CR30]--[@CR32]\]. An EtCO~2~ \< 10 mmHg after 20 minutes of CPR may be considered a component of a multimodal approach to TOR, particular for withholding ECPR \[[@CR33], [@CR34]\]. Although EtCO~2~ was not evaluated in the present study, several unexpected survivors underwent ECPR. Therefore, consideration of EtCO~2~ may improve the ALS TOR rule.

This study had several limitations. Firstly, this was an observational study, not an interventional study. Although prehospital TOR is not legally permitted in Japan, resuscitation efforts might not be conducted consistently in all OHCA patients. Secondly, SOS-KANTO 2012 was not a population-based study because it was conducted only in the Kanto area of Japan. Therefore, it is possible that our findings are not generalizable to other parts of Japan or other countries. However, the characteristics and outcomes of OHCA patients in this study were similar to those in other population-based studies in Japan and other countries \[[@CR7], [@CR10], [@CR11], [@CR18]\]. Finally, this study excluded pediatric patients and those with traumatic cardiac arrest; therefore, the effectiveness of the prehospital TOR rules for these populations is unclear.

Conclusions {#Sec15}
===========

The BLS and ALS TOR rules were useful for predicting neurologically unfavorable outcomes and mortality 1 month after the onset of OHCA of cardiac etiology. However, these rules should be applied cautiously to patients with OHCA of noncardiac etiology.

Key messages {#Sec16}
============

The BLS and ALS TOR rules were useful for predicting unfavorable neurological outcomes 1 month after onset of OHCA of cardiac etiology, demonstrating both a high specificity and PPV.The TOR rules should be applied with caution to patients with OHCA of noncardiac etiologies because these rules were observed to have a high PPV but a relatively low specificity.

Additional file {#Sec17}
===============

Additional file 1: Table S1.Presenting the characteristics of 13 unexpected survivors with favorable neurological outcomes. (DOCX 16 kb)
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